Do you have the same question? Follow this Question
Feb 17, 2026 - 01:14 PM
We’ve provided several answers to questions related to Apriso (Mesalamine) , see some other helpful Q&A related to this product.
Question: Can mesalamine cause skin rash?
Answer: Yes, mesalamine can cause skin rash as a side effect in some people. If you develop a rash while taking mesalamine, you should contact your healthcare provider, as it may indicate an allergic reaction or sensitivity to the medication.
Question: Is this medication compatible with Crohn syndrome treatment?
Answer: Yes, it is prescribed for inflammation of the digestive tract commonly known as Crohn syndrome. This compatibility is valuable for patients with various inflammatory bowel diseases.
Question: What are the available routes of administration?
Answer: The main route is oral (by mouth), but there are other formulations for rectal administration. Having multiple routes of administration can be valuable for patients with different needs or preferences.
Question: What is the protein binding percentage?
Answer: The protein binding is around 43%. Protein binding impacts how much of the drug is available to act in the body, which can affect efficacy and interactions with other medications.
Question: What is the strength of each capsule?
Answer: Each capsule contains 0.375 grams (375 mg) of mesalamine in an extended-release form. Extended-release means the medicine is released slowly over time, providing longer-lasting effects for symptom control.
